Cargando…

Knockout of ENO1 leads to metabolism reprogramming and tumor retardation in pancreatic cancer

The shift in glucose utilization from oxidative phosphorylation to glycolysis is the hallmark of tumor cells. The overexpression of ENO1, one of the key enzymes in the glycolysis process, has been identified in several cancers, however, its role in pancreatic cancer (PC) is yet unclear. This study i...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Qingru, Zhang, Kai, Sun, Tianjiao, Xu, Congcong, Zhao, Wei, Zhang, Zhiqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950624/
https://www.ncbi.nlm.nih.gov/pubmed/36845730
http://dx.doi.org/10.3389/fonc.2023.1119886